How do you manage patients with bleeding disorders, such as hemophilia, and those at risk of thromboembolic events?

1

---

Describe the indications for bone marrow transplantation and the steps involved in assessing patient eligibility and matching donors.

1

---

Can you discuss the challenges and potential complications associated with allogeneic bone marrow transplants?

1

---

What differentiates pediatric hematology from adult hematology, and how do you diagnose and treat blood disorders in children?

1

---

Describe the approach to managing a child with immune thrombocytopenic purpura (ITP).

1

---

How do you approach the diagnosis and counseling of patients with genetic hematologic disorders such as thalassemia or hemoglobinopathies?

1

---

Discuss the importance of carrier screening and genetic counseling for patients at risk of passing on inherited blood disorders.

1

---

How do you effectively communicate complex diagnoses, treatment plans, and potential risks with patients and their families?

1

---

Describe a situation where you provided clear instructions for at-home management of a patient with a chronic hematologic condition.

1

---

What ethical challenges may arise when recommending treatments for hematologic conditions, especially in cases where risks and benefits are complex?

1

---

How do you approach discussions about end-of-life care and palliative options for patients with advanced hematologic diseases?

1

---

Are you familiar with recent advancements in hematology research and treatment modalities? How do you stay informed about the latest developments?

1

---

Can you discuss the potential impact of emerging therapies, such as gene editing or targeted immunotherapies, on hematology practice?

1

---

How do you ensure culturally sensitive care when diagnosing and treating hematologic conditions, especially when dealing with patients from diverse backgrounds?

1

---

How do you collaborate with hematology-oncology specialists to provide comprehensive care for patients with both hematologic and oncologic conditions?

1

---